STOCK TITAN

Adamas Announces New Employment Inducement Grant

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Adamas Pharmaceuticals (Nasdaq: ADMS) has granted restricted stock units (RSUs) to three new employees, totaling 38,500 shares. These RSUs will vest over three years and are part of the Adamas Pharmaceuticals 2016 Inducement Plan, approved by the board in March 2016. The plan is designed to attract new talent to advance the company's mission of delivering innovative neurological therapies. For further details, visit www.adamaspharma.com.

Positive
  • The issuance of RSUs may enhance employee retention and motivation.
  • The plan aligns with the company's strategy to attract talent for its portfolio development.
Negative
  • None.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three new employees restricted stock units to acquire 38,500 shares of the company’s common stock. The restricted stock units vest over three years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company's board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

FAQ

What is the recent stock grant news from Adamas Pharmaceuticals?

Adamas Pharmaceuticals granted 38,500 restricted stock units to three new employees, vesting over three years as part of its 2016 Inducement Plan.

How many shares were granted by Adamas Pharmaceuticals?

A total of 38,500 shares were granted as restricted stock units to new employees.

What is the purpose of the 2016 Inducement Plan by Adamas Pharmaceuticals?

The 2016 Inducement Plan aims to attract new employees by offering equity grants.

How do restricted stock units vest at Adamas Pharmaceuticals?

The restricted stock units granted by Adamas vest over a period of three years.

ADMS

NASDAQ:ADMS

ADMS Rankings

ADMS Latest News

ADMS Stock Data

44.78M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Emeryville